Improving adherence to and persistence with oral therapy of osteoporosis

Survey of the utility of once-monthly bisphosphonate treatment for improvement of medication adherence in osteoporosis patients in Japan

(2014) Kazuya Makita et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Osteoporosis medication adherence: Physician perceptions vs. patients' utilization

(2013) Jeffrey R. Curtis et al.   BONE

Persistence with osteoporosis medication among newly-treated osteoporotic patients

(2013) Job F. M. van Boven et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Primary non-adherence to bisphosphonates in an integrated healthcare setting

(2013) K. Reynolds et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

Adherence with Medications Used to Treat Osteoporosis: Behavioral Insights

(2013) John T. Schousboe   Current Osteoporosis Reports

Osteoporosis Telephonic Intervention to Improve Medication Regimen Adherence

(2012) Daniel H. Solomon   ARCHIVES OF INTERNAL MEDICINE

The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis

(2012) Mickaël Hiligsmann et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Alendronate Adherence and Its Impact on Hip-Fracture Risk in Patients With Established Osteoporosis in Taiwan

(2011) T-C Lin et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effects of antiresorptive treatment on nonvertebral fracture outcomes

(2011) Dawn C Mackey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial

(2011) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009

(2010) S. Lee et al.   OSTEOPOROSIS INTERNATIONAL

Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors

(2010) S. M. Cadarette et al.   OSTEOPOROSIS INTERNATIONAL

Patient education in groups increases knowledge of osteoporosis and adherence to treatment: A two-year randomized controlled trial

(2010) Dorthe Nielsen et al.   PATIENT EDUCATION AND COUNSELING

Hip fractures in Italy: 2000–2005 extension study

(2009) P. Piscitelli et al.   OSTEOPOROSIS INTERNATIONAL

Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials

(2009) M. M. Wilkes et al.   OSTEOPOROSIS INTERNATIONAL

Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions

(2008) Becky A Briesacher et al.   PHARMACOTHERAPY